Cell-Meditated Inflammatory Pathway and Diabetic Retinopathy
细胞介导的炎症途径和糖尿病视网膜病变
基本信息
- 批准号:10368669
- 负责人:
- 金额:$ 35.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:APAF1 geneAdvanced DevelopmentAffectAntibodiesApoptosisApoptoticBiological AssayBiological MarkersBiomedical ResearchCASP3 geneCASP8 geneCASP9 geneCapillary Endothelial CellCaspaseCell AdhesionCell CommunicationCell Surface ReceptorsCellsCellular biologyCessation of lifeCoculture TechniquesDevelopmentDiabetes MellitusDiabetic RetinopathyDiseaseEarly InterventionEarly treatmentEndothelial CellsEnsureEnzymesEtiologyEventEyeEye diseasesFundingGene ExpressionGenesGoalsGrantHispanicHumanHuman CloningIndividualInflammatoryIntegrin alpha3IntegrinsInterventionJointsKnowledgeLaboratoriesLeadLearningLiteratureMeasuresMediatingMinority GroupsModelingMolecularMolecular BiologyOligonucleotidesPathologyPathway interactionsPeptide HydrolasesPeptidesPericytesPrediabetes syndromeProteinsRegulationReportingResearchResearch Project GrantsRetinaRoleSignal TransductionSignaling ProteinSmall Interfering RNAStudentsSystemTGFBI geneTherapeutic InterventionTimeTransforming Growth Factor betaangiogenesisbasecytochrome cdiabeticexperienceinhibitorinnovationmacrophagemonocytenovelosteosarcomapandemic diseaseprotein aminoacid sequencereceptorresponsesynthetic peptidetherapeutic target
项目摘要
Retinal pericytes are contractile cells adjacent to and provide support for endothelial cells of
capillaries, which are essential in the regulation of retinal vasculature in the eye. Early stages of
diabetic retinopathy are characterized by the loss of retinal pericytes, which lead to the
development of advanced-stage pathology including angiogenesis. Although much is known
about the etiology of diabetic retinopathy, the apoptotic pathway that incites retinal pericyte loss
remains unclear. Our preliminary studies reveal that monocyte-derived macrophages secrete
TGFβ1, which induces the expression and secretion of a TGFβ1-Induced, pro-apoptotic BIGH3
protein (TGFβ –Induced Gene Human Clone 3) leading to apoptosis of endothelial cells and
retinal pericytes. This cascade of events has been attributed to the primary cause of retinal
pericyte apoptosis and diabetic retinopathy. Macrophage TGF-β1 and BIGH3 are prediabetic
biomarkers, and potential therapeutic targets for intervention of diabetic retinopathy for diabetic
individuals. In the present study, we hypothesize that a similar macrophage-TGFβ–BIGH3
pathway may induce apoptosis in retinal pericytes. We will investigate the interaction between
endothelial cells and retinal pericytes, as well as macrophages’ role on retinal pericyte expression
of BIGH3 in response to TGFβ, and retinal pericyte apoptosis. Furthermore, we will also study
the association of BIGH3 with integrin, a trans-membrane signaling protein receptor and its role
to mediate retinal pericyte apoptosis. This novel study focuses on macrophage-mediated
molecular pathway to impact diabetic retinopathy and it will provide opportunities of therapeutic
intervention of this ocular eye disorder. Student trainees will be involved in these research
projects, providing valuable experience on biomedical research.
视网膜周细胞是收缩细胞,与之相邻,并为
毛细血管,这对于对视网膜脉管系统的调节至关重要。早期阶段
糖尿病性视网膜病的特征是视网膜周周的丧失,这导致
开发包括血管生成在内的晚期病理。虽然众所周知
关于糖尿病性视网膜病的病因,促进视网膜周细胞损失的凋亡途径
仍然不清楚。我们的初步研究表明,单核细胞衍生的巨噬细胞分泌
TGFβ1,诱导TGFβ1诱导的促凋亡Bigh3的表达和分泌
蛋白质(TGFβ - 诱导的基因人克隆3)导致内皮细胞凋亡和
视网膜周细胞。这串联的事件归因于视网膜的主要原因
周细胞凋亡和糖尿病性视网膜病。巨噬细胞TGF-β1和Bigh3是糖尿病前期
生物标志物和潜在的治疗靶标,用于干预糖尿病性糖尿病患者
在本研究中,我们假设类似的巨噬细胞-TGFβ– Bigh3
途径可能诱导永久性周细胞的凋亡。我们将研究
内皮细胞和永久性周细胞,以及巨噬细胞在永久性周细胞表达中的作用
Bigh3响应TGFβ和视网膜周细胞凋亡。此外,我们还将学习
Bigh3与整合素,反膜信号蛋白受体及其作用的关联
介导视网膜周细胞凋亡。这项新研究的重点是巨噬细胞介导的
撞击糖尿病性视网膜病的分子途径,它将提供治疗的机会
这种眼部眼部障碍的干预。学生学员将参与这些研究
项目,为生物医学研究提供宝贵的经验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW T C TSIN其他文献
ANDREW T C TSIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW T C TSIN', 18)}}的其他基金
Cell-Mediated Inflammatory Pathway and Diabetic Retinopathy-Administrative Supplement
细胞介导的炎症途径和糖尿病视网膜病变-管理补充剂
- 批准号:
10789444 - 财政年份:2022
- 资助金额:
$ 35.51万 - 项目类别:
Cell-Mediated Inflammatory Pathway and Diabetic Retinopathy-Administrative Supplement
细胞介导的炎症途径和糖尿病视网膜病变-管理补充剂
- 批准号:
10604916 - 财政年份:2022
- 资助金额:
$ 35.51万 - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Examining the multilevel factors on quality of end-of-life care among cancer patients in Puerto Rico
检查影响波多黎各癌症患者临终关怀质量的多层次因素
- 批准号:
10557584 - 财政年份:2023
- 资助金额:
$ 35.51万 - 项目类别:
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 35.51万 - 项目类别:
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 35.51万 - 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 35.51万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 35.51万 - 项目类别: